Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628
- 1 January 1995
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 33 (1) , 235-238
- https://doi.org/10.1128/jcm.33.1.235-238.1995
Abstract
For testing bacterial susceptibility to PD131628, a 5-micrograms disk and the following tentative interpretive criteria may be used: > or = 19 mm for susceptible (MIC, < or = 1.0 micrograms/ml), 16 to 18 mm for intermediate (MIC, 2.0 micrograms/ml), and < or = 15 mm for resistant (MIC, > or = 4.0 micrograms/ml). For standard quality control strains, the following limits are proposed: for Escherichia coli ATCC 25922, zones of 31 to 41 mm or a MIC of 0.002 to 0.016 micrograms/ml; for Pseudomonas aeruginosa ATCC 27853, zones of 26 to 34 mm or a MIC of 0.12 to 0.5 micrograms/ml; for Staphylococcus aureus ATCC 25923, zones of 27 to 33 mm; for Staphylococcus aureus ATCC 29213, a MIC of 0.03 to 0.12 micrograms/ml; and for Enterococcus faecalis ATCC 29212, a MIC of 0.12 to 0.5 micrograms/ml.Keywords
This publication has 8 references indexed in Scilit:
- Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacinJournal of Antimicrobial Chemotherapy, 1993
- In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1993
- Antibacterial activity of a 1,8-naphthyridine quinolone, PD131628Journal of Medical Microbiology, 1992
- In-vitro activity of PD 131628, a new quinolone antimicrobial agentJournal of Antimicrobial Chemotherapy, 1992
- Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628Diagnostic Microbiology and Infectious Disease, 1991
- Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesAntimicrobial Agents and Chemotherapy, 1991
- Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agentAntimicrobial Agents and Chemotherapy, 1991